As the pharmaceutical industry undertakes remarkable changes and advancements, spending for latest equipment and state-of-the-art technologies is growing to fulfill new demands.
The expanding expenditure for pharmaceutical equipment is entirely based on the considerable changes in the medicine industry along with aggressive competition. This variation is steered by pressures to curtail costs and augment performance and outcomes.
According to Senieer – A Pharmaceutical Equipment Manufacturer in China, the equipment associated with the pharmaceutical industry requires across the supply chain are developing, from the initial step to the final packaging and shipment. Prominent drivers of the change involve mergers and acquisitions, the globalization factor, and varying pipelines needing equipment and technology revolution.
Pharma Equipment Trends
Roughly 93% purchasers are interested in purchasing latest pharma equipment to upscale production and achieve better quality. Nearly 81% is interested in investing biopharmaceutical machinery, reflecting the varying product manufacturing procedures. 87% is interested in buying lab equipment while the massive 77% is interested in better packaging machinery.
Processing Equipment
Processing machinery such as tableting, granulation compactors and encapsulating equipment are the most trending options. Also, mixers, counting machinery, form/fill equipment and packaging machinery are the major focus of most of the buyers.
As far as semi-solid dose processing is concerned, blenders, granulation equipment, heating and cooling machinery and synthesizing machinery are the major attractions for buyers interested in pharmaceutical industry. Liquid dose processing, on the other hand, requires latest filtration equipment that’s also grabbing buyer’s attention in 2019.
Latest Bioprocessing Equipment
Another popular pharmaceutical equipment buying trend that is on storm is the bioprocessing machinery. This category includes general bioprocessing equipment, incubators and stirrers/mixers. Also, buyers are interested in purchasing cell culture biological shakers, bioreactors
Notably, 50% of buyers who are interested in biopharma equipment buy filtration equipment whereas only 39% is interested in disposable equipment. Nearly, 38% focuses on separation and chromatography equipment.
Packaging Equipment
Form/fill and packaging equipment such as sealing/capping machinery is also the well-known type of machinery which is generally bought for primary packaging. Over 25% of buyers show interest in purchasing aseptic seal equipment used primarily in the manufacturing of eye drops and other product assembly lines of different types of patches and inhalers.
When it comes to secondary packaging, roughly 50% purchasers opt for printers and labeling equipment. Over 25% prefer bulk packaging machinery and other types of tamper-evident processes.
Handling Surplus Equipment
The ever-evolving mergers and acquisitions in recent years and varying kinds of processing procedures has contributed to surplus equipment, impacting expansion and growth of used pharma equipment market. Generally, the machinery can be reused to meet present-day requirements. This is incredibly useful in situations when the purchasers are short of capital and are looking to invest in equipment that is no longer used.
Outsourcing is the Latest Trend
Many companies have been teaming up with contract service providers in order to amplify their capacities to meet the varying needs of sponsor firms that are progressively outsourcing to attain maximum savings and also get their hands on latest technologies. Today, more and more pharmaceutical companies are turning to automated solutions and latest technical innovations in order to upscale their capacity to produce powerful and more effective medicines.
What’s Next?
One of the leading trends in pharmaceutical sector is the production of 3D bioprinting. It is also expected that in the near future, the 3D technology will capture the pharma industry just like all the other major industry sectors. Manufacturers are also hopeful about other latest innovations that can help them produce bulk compounds within controlled environment.
